PIRRO, Federico et al. Risankizumab Versus Secukinumab: A Real-World Efficacy and Cost per Responder Comparison in Patients With Psoriasis in Italy. Dermatology Practical & Conceptual, [S. l.], v. 15, n. 1, p. 4838, 2025. DOI: 10.5826/dpc.1501a4838. Disponível em: https://mail.dpcj.org/index.php/dpc/article/view/4838.. Acesso em: 19 apr. 2026.